Anthony Gershlick

Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trial

Banning A, Adriaenssens T, Berry C, Bogaerts K, Erglis A, Distelmaier K, Guagliumi G, Haine S, Kastrati A, Massberg S, Orban M, Myrmel T, Vuylsteke A, Alfonso F, Van de Werf F, Verheugt F, Flather M, Sabaté M, Vrints C, Gershlick A

February 5, 2021 | 10.4244/EIJ-D-20-01076

Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left main trifurcation disease: the EXCEL trial

Kandzari D, Gershlick A, Serruys P, Leon M, Morice M, Simonton C, Lembo N, Mansour S, Sabaté M, Sabik J, Kappetein A, Dressler O, Stone G

December 18, 2020 | 10.4244/EIJ-D-19-00686

Complete revascularisation in the STEMI patient: is it worth the effort?

Gershlick A, Banning A

June 25, 2020 | 10.4244/EIJV16I3A34

Spotlight on N-STEMI ACS: getting the right patients the right treatment, and at the right time

Kite T, Gersh B, Gershlick A

December 20, 2019 | 10.4244/EIJV15I12A196

Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club

Galassi A, Werner G, Boukhris M, Azzalini L, Mashayekhi K, Carlino M, Avran A, Konstantinidis N, Grancini L, Bryniarski L, Garbo R, Bozinovic N, Gershlick A, Rathore S, Di Mario C, Louvard Y, Reifart N, Sianos G

June 20, 2019 | 10.4244/EIJ-D-18-00826

Invasive cardiovascular needs in South Africa: a view from afar up close

Holmes D, King S, Gershlick A, Marco J, Koolen J, Pichard A, Bassand J-P, Kettles D, Wijns W, Ntsekhe M

October 19, 2018 | 10.4244/EIJV14I8A153

STEMI – are we there yet?

Gershlick A

March 20, 2018 | 10.4244/EIJV13I16A304

Contemporary considerations in left main stem treatment

Gershlick A, Banning A

November 20, 2017 | 10.4244/EIJV13I10A179

Will this trial change my practice? The Dual Antiplatelet Therapy (DAPT) study – 12 or 30 months of dual antiplatelet therapy after drug-eluting stents

Grundeken M.J, Lansky A, Tanguay J, Gershlick A, Baumbach A, Cuisset T

July 20, 2015 | 10.4244/EIJV11I3A71

Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI

Brener S, Dambrink J-H, Maehara A, Chowdhary S, Gershlick A, Généreux P, Koolen J, Mehran R, Fahy M, Gibson CM, Stone G

February 20, 2014 | 10.4244/EIJV9I10A201

Highlights from The Experts “Live”, 4th annual congress of the Euro CTO Club, London 2012

Di Mario C, Hildick-Smith D, Gershlick A, Ghione M, Agudo P, Alahmar A, Galassi A, Werner G

April 19, 2013 | 10.4244/EIJV8I12A208

Hybrid revascularisation in multivessel coronary artery disease: could a combination of CABG and PCI be the best option in selected patients?

Wrigley B, Dubey G, Spyt T, Gershlick A

March 22, 2013 | 10.4244/EIJV8I11A202

Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design

Kelly D, McCann G, Blackman D, Curzen N, Dalby M, Greenwood J, Fairbrother K, Shipley L, Kelion A, Heatherington S, Khan J, Nazir S, Alahmar A, Flather M, Swanton H, Schofield P, Gunning M, Hall R, Gershlick A

February 22, 2013 | 10.4244/EIJV8I10A183

Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study

Hamon M, Rao S, Steg G, Valgimigli M, Verheugt F, Marso S, Gershlick A, Wang Y, Deliargyris E

August 24, 2012 | 10.4244/EIJV8I4A76

Recanalisation of Chronic Total coronary Occlusions: 2012 consensus document from the EuroCTO club

Sianos G, Werner G, Galassi A, Papafaklis M, Escaned J, Hildick-Smith D, Christiansen E, Gershlick A, Carlino M, Karlas A, Konstantinidis N, Tomasello S, Di Mario C, Reifart N

May 15, 2012 | 10.4244/EIJV8I1A21

Discontinuation of metformin in the setting of coronary angiography: clinical uncertainty amongst physicians reflecting a poor evidence base

Maznyczka A, Myat A, Gershlick A

January 20, 2012 | 10.4244/EIJV7I9A175

In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry

Galassi A, Tomasello S, Reifart N, Werner G, Sianos G, Bonnier H, Sievert H, Ehladad S, Bufe A, Schofer J, Gershlick A, Hildick-Smith D, Escaned J, Erglis A, Sheiban I, Thuesen L, Serra A, Christiansen E, Buettner A, Costanzo L, Barrano G, Di Mario C

August 30, 2011 | 10.4244/EIJV7I4A77

Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial

Duckers H, Houtgraaf J, Hehrlein C, Schofer J, Waltenberger J, Gershlick A, Bartunek J, Nienaber C, Naber C, Macaya C, Peters N, Smits P, Siminiak T, van Mieghem W, Legrand V, Serruys P

February 21, 2011

Cost-effectiveness of the Endeavor stent in de novo native coronary artery lesions updated with contemporary data

Remak E, Manson S, Hutton J, Brasseur P, Olivier E, Gershlick A

February 25, 2010

Health economics: drug-eluting stents – are they worth the money?

Gershlick A, Fearn S

August 20, 2008

Anthony Gershlick

Latest news